Healthcare resource utilization, costs and treatment associated with myasthenia gravis exacerbations among patients with myasthenia gravis in the USA: a retrospective analysis of claims data
Aim: There are limited data on the clinical and economic burden of exacerbations in patients with myasthenia gravis (MG). We assessed patient clinical characteristics, treatments and healthcare resource utilization (HCRU) associated with MG exacerbation. Patients & methods: This was a retrospe...
Main Authors: | Julia Pisc, Angela Ting, Michelle Skornicki, Omar Sinno, Edward Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Becaris Publishing Limited
2023-12-01
|
Series: | Journal of Comparative Effectiveness Research |
Subjects: |
Similar Items
-
Real-World Persistence and Treatment Interval in Patients with Diabetic Macular Edema Treated with Anti-Vascular Endothelial Growth Factors in the USA
by: Sophie J. Bakri, et al.
Published: (2023-06-01) -
Validation of Claims-Based Algorithm for Lyme Disease, Massachusetts, USA
by: Noelle M. Cocoros, et al.
Published: (2023-09-01) -
A Critical Examination for the Pricing of Eculizumab and Efgartigimod in Myasthenia Gravis
by: Paul C. Langley
Published: (2021-10-01) -
How adequate is measles surveillance in the United States? Investigations of measles-like illness, 2010–2017
by: Susannah L. McKay, et al.
Published: (2021-03-01) -
Gout and dementia in the elderly: a cohort study of Medicare claims
by: Jasvinder A. Singh, et al.
Published: (2018-11-01)